Carl F. Nathan
Directeur/Bestuurslid bij Tres Cantos Open Lab Foundation
Oorsprong van het eerstegraads netwerk van Carl F. Nathan
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Tres Cantos Open Lab Foundation
 Tres Cantos Open Lab Foundation Miscellaneous Commercial ServicesCommercial Services Tres Cantos Open Lab Foundation provides research facilities for charity. The non-profit company is based in Guildford, UK.
7
| Non-Profit Organization | Miscellaneous Commercial Services | 7 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Carl F. Nathan via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| THE MEDICINES COMPANY | Pharmaceuticals: Major | Director/Board Member | |
Global Alliance for TB Drug Development
 Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Pharmaceuticals: Generic | Chief Executive Officer | |
| Brown University | College/University | Undergraduate Degree | |
| ABBOTT INDIA LIMITED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Imperial College London | College/University | Doctorate Degree | |
| University of Cambridge | College/University | Graduate Degree | |
Wellington Partners GmbH
 Wellington Partners GmbH Investment ManagersFinance Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto. | Investment Managers | Private Equity Investor | |
| Icahn School of Medicine at Mount Sinai | College/University | Doctorate Degree | |
| Knoll Pharmaceutical Co. | Chief Tech/Sci/R&D Officer | ||
| Hudson-Douglas Ltd. | President | ||
| AN2 THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| SYNERGY PHARMACEUTICALS INC | Pharmaceuticals: Major | Chairman |
Statistieken
Internationaal
| Verenigde Staten | 9 |
| Verenigd Koninkrijk | 3 |
| Zwitserland | 2 |
| India | 2 |
| Duitsland | 2 |
Sectoraal
| Health Technology | 7 |
| Consumer Services | 5 |
| Finance | 2 |
Operationeel
| Director/Board Member | 11 |
| Chief Tech/Sci/R&D Officer | 4 |
| Independent Dir/Board Member | 3 |
| Corporate Officer/Principal | 3 |
| President | 2 |
Sterkste connecties
- Beurs
- Insiders
- Carl F. Nathan
- Bedrijfsconnecties
